111 related articles for article (PubMed ID: 27089389)
1. Tolfenamic acid downregulates β-catenin in colon cancer.
Ha T; Lou Z; Baek SJ; Lee SH
Int Immunopharmacol; 2016 Jun; 35():287-293. PubMed ID: 27089389
[TBL] [Abstract][Full Text] [Related]
2. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
Pathi S; Li X; Safe S
Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
[TBL] [Abstract][Full Text] [Related]
3. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta).
Clifford RL; Deacon K; Knox AJ
J Biol Chem; 2008 Dec; 283(51):35337-53. PubMed ID: 18952601
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the transforming growth factor-β pathway by tolfenamic acid via the ERK MAP kinase pathway.
Zhang X; Min KW; Liggett J; Baek SJ
Carcinogenesis; 2013 Dec; 34(12):2900-7. PubMed ID: 23864386
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-induced down-regulation of beta-catenin in colon cancer cells by a proteasome-independent specific pathway.
Prévotat L; Filomenko R; Solary E; Jeannin JF; Bettaieb A
Gastroenterology; 2006 Oct; 131(4):1142-52. PubMed ID: 17030184
[TBL] [Abstract][Full Text] [Related]
6. Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
Abdelrahim M; Baker CH; Abbruzzese JL; Safe S
J Natl Cancer Inst; 2006 Jun; 98(12):855-68. PubMed ID: 16788159
[TBL] [Abstract][Full Text] [Related]
7. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
8. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
Mirzoeva S; Franzen CA; Pelling JC
Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
[TBL] [Abstract][Full Text] [Related]
9. Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2.
Puca R; Nardinocchi L; D'Orazi G
J Exp Clin Cancer Res; 2008 Jul; 27(1):22. PubMed ID: 18644116
[TBL] [Abstract][Full Text] [Related]
10. Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.
Foreman JE; Sorg JM; McGinnis KS; Rigas B; Williams JL; Clapper ML; Gonzalez FJ; Peters JM
Mol Carcinog; 2009 Oct; 48(10):942-52. PubMed ID: 19415698
[TBL] [Abstract][Full Text] [Related]
11. Bridge-1 is expressed in human breast carcinomas: silencing of Bridge-1 decreases Smad2, Smad3 and Smad4 expression in MCF-7 cells, a human breast cancer cell line.
Banz-Jansen C; Münchow B; Diedrich K; Finas D
Arch Gynecol Obstet; 2011 Dec; 284(6):1543-9. PubMed ID: 21448710
[TBL] [Abstract][Full Text] [Related]
12. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines.
Dillard AC; Lane MA
Mol Carcinog; 2007 Apr; 46(4):315-29. PubMed ID: 17219422
[TBL] [Abstract][Full Text] [Related]
13. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
[TBL] [Abstract][Full Text] [Related]
14. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive Properties of Tolfenamic Acid: A Mechanistic Review.
Feldman D; Leahy E; Lee SH
Curr Med Chem; 2018; 25(14):1598-1608. PubMed ID: 28413959
[TBL] [Abstract][Full Text] [Related]
16. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
Chang JW; Kang SU; Choi JW; Shin YS; Baek SJ; Lee SH; Kim CH
Free Radic Biol Med; 2014 Feb; 67():115-30. PubMed ID: 24216474
[TBL] [Abstract][Full Text] [Related]
17. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
Calviello G; Resci F; Serini S; Piccioni E; Toesca A; Boninsegna A; Monego G; Ranelletti FO; Palozza P
Carcinogenesis; 2007 Jun; 28(6):1202-9. PubMed ID: 17183061
[TBL] [Abstract][Full Text] [Related]
19. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
Konduri S; Colon J; Baker CH; Safe S; Abbruzzese JL; Abudayyeh A; Basha MR; Abdelrahim M
Mol Cancer Ther; 2009 Mar; 8(3):533-42. PubMed ID: 19258429
[TBL] [Abstract][Full Text] [Related]
20. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]